| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Anteris Technologies Global Corp.
13D
AVR · 03675P102
|
16.2% |
1/29/2026
Event 1/22/2026
|
||||
| Medtronic plc | 16.2% | |||||
| Covidien Group S.a.r.l. | 16.2% | |||||
| Schedule 13G · 2 securities · passive | ||||||
|
MiniMed Group, Inc.
13G/A
MMED · 60365F109
|
0% |
10/16/2026
Event 10/15/2026
|
||||
|
Orchestra BioMed Holdings, Inc.
13G/A
OBIO · 68572M106
|
17.8% |
2/27/2026
Event 12/31/2025
|
||||
| Medtronic plc | 17.8% | |||||
| Covidien Group S.a.r.l. | 17.8% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.